arrow
A

Anahid Ehteda

children's cancer institute
H指数:17
被引数:976

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma

联合抑制FACT和BET破坏转录以抑制弥漫性中线胶质瘤小鼠模型的肿瘤生长

2026-01-140
PRE
CHROMATIN REMODELING WITH COMBINED FACT AND BET INHIBITION DISRUPTS ONCOGENIC TRANSCRIPTION IN DIFFUSE MIDLINE GLIOMA

联合FACT和BET抑制的染色质重塑破坏弥漫性中线胶质瘤中的致癌转录

2025-11-010
OAAI
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic

高通量体外药物筛选和体内研究将fenretinide确定为一种能够穿透血脑屏障的DMG治疗药物。

2025-02-120
PRE
TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG
2021-06-010
OAAI
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG
2021-04-0131
OAAI
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma (vol 141, pg 253, 2019)
2018-11-274
OAAI
International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma
2018-11-1630
PREAI
The FACT histone chaperone complex is highly expressed in aggressive drug refractory childhood cancers and the anti-FACT compound CBL0137 represents a highly promising therapeutic approach in this setting
2015-08-010
PRE